tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andreas Argyrides, 121 are a BUY (84.03%), 22 are a HOLD (15.28%), 1 are a SELL (0.69%).
Analyst Andreas Argyrides, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 37.42% that have a potential upside of 42.34% achieved within 144 days.
Andreas Argyrides’s has documented 287 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on OCUL, Ocular Therapeutix at 15-Sep-2026.
Analyst best performing recommendations are on MNPR (MONOPAR THERAPEUTICS).
The best stock recommendation documented was for MNPR (MONOPAR THERAPEUTICS) at 9/3/2025. The price target of $77 was fulfilled within 22 days with a profit of $40.79 (112.65%) receiving and performance score of 51.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Mar-2024
$21
$13.6 (183.78%)
$23
1 months 7 days ago
(25-Aug-2026)
0/17 (0%)
$12.09 (135.69%)
Buy Since 02-Jun-2023
$29
$21.6 (291.89%)
$32
1 months 7 days ago
(25-Aug-2026)
0/9 (0%)
$20.09 (225.48%)
Buy Since 07-Aug-2026
$12
$4.6 (62.16%)
$47
1 months 25 days ago
(07-Aug-2026)
1/2 (50%)
$1.28 (11.94%)
12
Buy Since 15-Dec-2025
$18
$10.6 (143.24%)
$20
3 months 10 days ago
(22-Jun-2026)
15/18 (83.33%)
$8.93 (98.46%)
91
Buy Since 22-Nov-2017
$12
$4.6 (62.16%)
$37
4 months 17 days ago
(15-May-2026)
3/11 (27.27%)
$6.28 (109.79%)
65
Which stock is Andreas Argyrides most bullish on?
Which stock is Andreas Argyrides most reserved on?
What Year was the first public recommendation made by Andreas Argyrides?
